Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment vs Tata India Pharma and Healthcare Fund Direct Plan Growth
NAV, returns and costs — not a recommendation.
 Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment |  Tata India Pharma and Healthcare Fund Direct Plan Growth | |
|---|---|---|
| NAV | ₹25.83 | ₹38.3028 |
| NAV date | 2026-09-30 | 2026-09-30 |
| 1 year | +11.92% | +9.46% |
| 3 year (p.a.) | +15.14% | +18.81% |
| 5 year (p.a.) | +8.05% | +14.16% |
| Expense ratio | 0.84% | 0.67% |
| Fund size | ₹950.31 Cr | ₹1386.99 Cr |
| Risk | — | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.